Bio-Gene Technology Ltd BGT.AX
AUD0.02
Last Updated: Aug 07, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
BGT.AX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Bio-Gene Technology Ltd is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Bio-Gene Technology Ltd. Stock Analysis BGT.AX
Australia Materials Nano Cap Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. Its products are based on a naturally occurring class of compounds proven to overcome resistance to control pests with minimal impact on human health and the environment. Its products have multiple applications across crop protection, grain storage, public health and consumer uses. Flavocide and Qcide are the Company’s lead beta-triketone insecticide products. Flavocide is a natural beta-triketone molecule produced synthetically by a chemical process. Qcide is a natural oil product containing tasmanone as the active constituent. The oil is extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana), by utilizing a steam distillation process. The firm operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.
Bio-Gene Technology Ltd (BGT.AX) Chart
Financial Metrics & Statements of Bio-Gene Technology Ltd (BGT.AX)
FAQ's for Bio-Gene Technology Ltd (BGT.AX)
- As of August 2026, Bio-Gene Technology Ltd BGT.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bio-Gene Technology Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Bio-Gene Technology Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Bio-Gene Technology Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Bio-Gene Technology Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Bio-Gene Technology Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Bio-Gene Technology Ltd (BGT.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
